 David Mathes
Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 25 | 2023 | 68 | 8.340 |
Why?
| | Perforator Flap | 9 | 2023 | 22 | 4.010 |
Why?
| | Surgical Flaps | 10 | 2018 | 121 | 3.100 |
Why?
| | Surgery, Plastic | 5 | 2023 | 25 | 2.240 |
Why?
| | Epigastric Arteries | 11 | 2023 | 18 | 1.900 |
Why?
| | Transplantation Tolerance | 8 | 2016 | 30 | 1.900 |
Why?
| | Skin Transplantation | 9 | 2018 | 57 | 1.860 |
Why?
| | Microsurgery | 8 | 2020 | 59 | 1.640 |
Why?
| | Composite Tissue Allografts | 4 | 2016 | 8 | 1.620 |
Why?
| | Graft Survival | 14 | 2020 | 446 | 1.610 |
Why?
| | Vascularized Composite Allotransplantation | 3 | 2020 | 22 | 1.590 |
Why?
| | Facial Transplantation | 4 | 2014 | 9 | 1.520 |
Why?
| | Graft Rejection | 11 | 2016 | 513 | 1.490 |
Why?
| | Hand Transplantation | 5 | 2011 | 9 | 1.440 |
Why?
| | Free Tissue Flaps | 3 | 2022 | 32 | 1.380 |
Why?
| | Breast Neoplasms | 10 | 2023 | 1862 | 1.180 |
Why?
| | Surgical Wound Dehiscence | 3 | 2023 | 19 | 1.180 |
Why?
| | Transplantation Chimera | 6 | 2014 | 51 | 1.170 |
Why?
| | Bone Marrow Transplantation | 6 | 2014 | 239 | 1.150 |
Why?
| | Acellular Dermis | 3 | 2022 | 12 | 1.070 |
Why?
| | Transplantation, Homologous | 14 | 2016 | 377 | 1.060 |
Why?
| | Breast Implants | 3 | 2023 | 13 | 1.050 |
Why?
| | Immune Tolerance | 7 | 2014 | 323 | 1.030 |
Why?
| | Rectus Abdominis | 3 | 2021 | 9 | 1.020 |
Why?
| | Fat Necrosis | 2 | 2022 | 8 | 0.980 |
Why?
| | Angiography | 5 | 2022 | 174 | 0.960 |
Why?
| | Breast Implantation | 2 | 2022 | 6 | 0.930 |
Why?
| | Body Dysmorphic Disorders | 1 | 2023 | 5 | 0.900 |
Why?
| | Rhinoplasty | 1 | 2023 | 23 | 0.860 |
Why?
| | Preoperative Care | 5 | 2012 | 319 | 0.860 |
Why?
| | Venous Thromboembolism | 2 | 2023 | 231 | 0.850 |
Why?
| | Enoxaparin | 1 | 2023 | 52 | 0.840 |
Why?
| | Vascular Surgical Procedures | 2 | 2019 | 259 | 0.820 |
Why?
| | Postoperative Complications | 10 | 2023 | 2128 | 0.800 |
Why?
| | Transplant Donor Site | 1 | 2021 | 4 | 0.780 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2016 | 520 | 0.770 |
Why?
| | Subcutaneous Tissue | 1 | 2021 | 17 | 0.770 |
Why?
| | Pressure Ulcer | 2 | 2011 | 31 | 0.720 |
Why?
| | Anticoagulants | 2 | 2023 | 550 | 0.690 |
Why?
| | Retrospective Studies | 23 | 2023 | 12542 | 0.690 |
Why?
| | Abdominal Wall | 2 | 2010 | 24 | 0.670 |
Why?
| | Kidney Transplantation | 5 | 2012 | 541 | 0.650 |
Why?
| | Tissue Transplantation | 3 | 2012 | 11 | 0.620 |
Why?
| | Surgical Wound Infection | 5 | 2023 | 248 | 0.610 |
Why?
| | Nipples | 1 | 2018 | 6 | 0.610 |
Why?
| | Tomography, X-Ray Computed | 3 | 2012 | 2279 | 0.580 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2016 | 20 | 0.550 |
Why?
| | Humans | 59 | 2023 | 114623 | 0.540 |
Why?
| | Tissue and Organ Harvesting | 2 | 2014 | 62 | 0.540 |
Why?
| | Patient Safety | 1 | 2019 | 277 | 0.530 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 267 | 0.510 |
Why?
| | Practice Patterns, Physicians' | 3 | 2023 | 1177 | 0.490 |
Why?
| | Myocutaneous Flap | 1 | 2014 | 3 | 0.480 |
Why?
| | Groin | 1 | 2014 | 13 | 0.470 |
Why?
| | Perineum | 1 | 2014 | 25 | 0.470 |
Why?
| | Pregnancy, Animal | 1 | 2014 | 52 | 0.460 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2014 | 32 | 0.460 |
Why?
| | Pelvis | 1 | 2014 | 90 | 0.440 |
Why?
| | Patient Satisfaction | 2 | 2023 | 578 | 0.430 |
Why?
| | Dogs | 5 | 2016 | 334 | 0.430 |
Why?
| | Female | 32 | 2023 | 59466 | 0.420 |
Why?
| | Breast | 2 | 2011 | 139 | 0.410 |
Why?
| | Diphtheria Toxin | 3 | 2022 | 51 | 0.410 |
Why?
| | Face | 2 | 2013 | 164 | 0.400 |
Why?
| | Attitude of Health Personnel | 2 | 2009 | 975 | 0.400 |
Why?
| | Interleukin-2 | 3 | 2023 | 413 | 0.400 |
Why?
| | Swine, Miniature | 7 | 2014 | 71 | 0.390 |
Why?
| | Middle Aged | 17 | 2023 | 26719 | 0.390 |
Why?
| | Immunotoxins | 2 | 2023 | 33 | 0.390 |
Why?
| | Lymphoma, T-Cell, Cutaneous | 2 | 2023 | 40 | 0.380 |
Why?
| | Communications Media | 1 | 2011 | 5 | 0.380 |
Why?
| | Models, Animal | 3 | 2012 | 344 | 0.370 |
Why?
| | Antibiotic Prophylaxis | 1 | 2012 | 96 | 0.370 |
Why?
| | Computed Tomography Angiography | 2 | 2022 | 97 | 0.360 |
Why?
| | Swine | 9 | 2014 | 700 | 0.360 |
Why?
| | Osteomyelitis | 1 | 2011 | 101 | 0.350 |
Why?
| | Coitus | 1 | 2010 | 27 | 0.350 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2010 | 39 | 0.340 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 105 | 0.340 |
Why?
| | Internet | 2 | 2011 | 596 | 0.330 |
Why?
| | Facial Injuries | 1 | 2009 | 17 | 0.330 |
Why?
| | Mastectomy | 4 | 2023 | 99 | 0.320 |
Why?
| | Traumatology | 1 | 2009 | 23 | 0.320 |
Why?
| | Arteries | 2 | 2013 | 247 | 0.320 |
Why?
| | Amputation, Traumatic | 1 | 2009 | 22 | 0.320 |
Why?
| | Hand Injuries | 1 | 2009 | 33 | 0.310 |
Why?
| | Magnetic Resonance Angiography | 1 | 2010 | 219 | 0.310 |
Why?
| | Vagina | 1 | 2010 | 146 | 0.310 |
Why?
| | Follow-Up Studies | 8 | 2021 | 4411 | 0.310 |
Why?
| | Length of Stay | 2 | 2023 | 962 | 0.300 |
Why?
| | Treatment Outcome | 11 | 2023 | 9084 | 0.300 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2008 | 19 | 0.300 |
Why?
| | Thigh | 1 | 2008 | 53 | 0.290 |
Why?
| | Skin Neoplasms | 3 | 2023 | 756 | 0.290 |
Why?
| | Mastectomy, Segmental | 2 | 2017 | 76 | 0.290 |
Why?
| | Wounds and Injuries | 2 | 2012 | 745 | 0.280 |
Why?
| | Cannabis | 2 | 2023 | 384 | 0.280 |
Why?
| | Orthopedics | 1 | 2009 | 121 | 0.280 |
Why?
| | Back | 1 | 2006 | 10 | 0.280 |
Why?
| | Adult | 12 | 2023 | 30528 | 0.260 |
Why?
| | Animals | 19 | 2023 | 31694 | 0.260 |
Why?
| | Societies, Medical | 1 | 2009 | 663 | 0.250 |
Why?
| | Histocompatibility | 3 | 2014 | 26 | 0.250 |
Why?
| | Transplantation Conditioning | 3 | 2016 | 151 | 0.240 |
Why?
| | Anastomosis, Surgical | 3 | 2020 | 136 | 0.240 |
Why?
| | Immunosuppressive Agents | 6 | 2014 | 646 | 0.230 |
Why?
| | Head and Neck Neoplasms | 2 | 2022 | 427 | 0.230 |
Why?
| | Fetus | 2 | 2005 | 699 | 0.230 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2023 | 14 | 0.220 |
Why?
| | Sternotomy | 1 | 2023 | 18 | 0.220 |
Why?
| | Body Contouring | 1 | 2023 | 8 | 0.220 |
Why?
| | Mandibular Fractures | 1 | 2023 | 9 | 0.220 |
Why?
| | Malocclusion | 1 | 2023 | 23 | 0.220 |
Why?
| | Insurance | 1 | 2023 | 11 | 0.220 |
Why?
| | Sezary Syndrome | 1 | 2023 | 43 | 0.220 |
Why?
| | Skull Fractures | 1 | 2023 | 28 | 0.220 |
Why?
| | Pain, Postoperative | 3 | 2023 | 191 | 0.220 |
Why?
| | Weight Loss | 1 | 2008 | 641 | 0.210 |
Why?
| | Mycosis Fungoides | 1 | 2023 | 60 | 0.210 |
Why?
| | Hindlimb | 2 | 2003 | 130 | 0.210 |
Why?
| | Seroma | 1 | 2022 | 3 | 0.200 |
Why?
| | Extremities | 2 | 2002 | 113 | 0.200 |
Why?
| | Clinical Protocols | 1 | 2023 | 233 | 0.200 |
Why?
| | Incidental Findings | 1 | 2022 | 70 | 0.200 |
Why?
| | Cyclosporine | 3 | 2016 | 161 | 0.190 |
Why?
| | Body Mass Index | 1 | 2008 | 1956 | 0.190 |
Why?
| | Hypotension | 1 | 2022 | 116 | 0.180 |
Why?
| | Magnetic Resonance Imaging | 1 | 2011 | 3039 | 0.180 |
Why?
| | Epidermal Growth Factor | 1 | 2021 | 161 | 0.180 |
Why?
| | United States | 7 | 2023 | 12176 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 2 | 2014 | 339 | 0.180 |
Why?
| | Time Factors | 6 | 2014 | 6112 | 0.180 |
Why?
| | Flow Cytometry | 4 | 2020 | 1083 | 0.170 |
Why?
| | Bone Transplantation | 1 | 2001 | 98 | 0.170 |
Why?
| | Risk Factors | 5 | 2023 | 8628 | 0.170 |
Why?
| | Analgesics, Opioid | 2 | 2023 | 771 | 0.170 |
Why?
| | Abdomen | 2 | 2010 | 99 | 0.170 |
Why?
| | Antigens | 2 | 2016 | 318 | 0.160 |
Why?
| | Keloid | 1 | 2019 | 7 | 0.160 |
Why?
| | Dermis | 1 | 2019 | 30 | 0.160 |
Why?
| | Incidence | 2 | 2023 | 2311 | 0.160 |
Why?
| | Postoperative Period | 2 | 2023 | 289 | 0.160 |
Why?
| | Reoperation | 2 | 2017 | 514 | 0.150 |
Why?
| | Fluorouracil | 1 | 2019 | 152 | 0.150 |
Why?
| | Tattooing | 1 | 2018 | 11 | 0.150 |
Why?
| | Indocyanine Green | 2 | 2022 | 12 | 0.150 |
Why?
| | Chimera | 2 | 2011 | 59 | 0.140 |
Why?
| | Data Collection | 2 | 2011 | 620 | 0.140 |
Why?
| | Graft vs Host Disease | 2 | 2016 | 212 | 0.140 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2017 | 76 | 0.140 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 2016 | 71 | 0.140 |
Why?
| | Prospective Studies | 3 | 2021 | 6217 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 2 | 2010 | 510 | 0.140 |
Why?
| | Opioid-Related Disorders | 1 | 2023 | 413 | 0.130 |
Why?
| | Hernia, Ventral | 1 | 2016 | 18 | 0.130 |
Why?
| | Mycophenolic Acid | 1 | 2016 | 77 | 0.130 |
Why?
| | Bupivacaine | 1 | 2016 | 31 | 0.130 |
Why?
| | Muscle, Skeletal | 2 | 2006 | 1472 | 0.130 |
Why?
| | Surgical Mesh | 1 | 2016 | 40 | 0.130 |
Why?
| | Herniorrhaphy | 1 | 2016 | 48 | 0.130 |
Why?
| | Leukocytes | 1 | 2016 | 276 | 0.120 |
Why?
| | Whole-Body Irradiation | 2 | 2012 | 73 | 0.120 |
Why?
| | Lymphocyte Culture Test, Mixed | 1 | 2014 | 41 | 0.120 |
Why?
| | Myeloablative Agonists | 1 | 2014 | 21 | 0.120 |
Why?
| | Patient Selection | 2 | 2008 | 641 | 0.120 |
Why?
| | Cadaver | 2 | 2010 | 299 | 0.120 |
Why?
| | False Negative Reactions | 1 | 2014 | 48 | 0.120 |
Why?
| | CD3 Complex | 1 | 2014 | 92 | 0.120 |
Why?
| | Multivariate Analysis | 3 | 2016 | 1430 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 4620 | 0.110 |
Why?
| | Risk Assessment | 2 | 2014 | 2967 | 0.110 |
Why?
| | False Positive Reactions | 1 | 2014 | 109 | 0.110 |
Why?
| | Dissection | 1 | 2014 | 51 | 0.110 |
Why?
| | Allografts | 1 | 2014 | 122 | 0.110 |
Why?
| | Temporal Arteries | 1 | 2014 | 47 | 0.110 |
Why?
| | Histocompatibility Antigens | 1 | 2014 | 98 | 0.110 |
Why?
| | Random Allocation | 1 | 2014 | 335 | 0.110 |
Why?
| | Pain Management | 1 | 2016 | 288 | 0.110 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 170 | 0.110 |
Why?
| | Prosthesis Failure | 1 | 2014 | 115 | 0.110 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 26 | 0.110 |
Why?
| | Health Care Costs | 1 | 2016 | 381 | 0.110 |
Why?
| | Prostheses and Implants | 1 | 2014 | 137 | 0.100 |
Why?
| | Recurrence | 2 | 2019 | 935 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1879 | 0.100 |
Why?
| | Regional Blood Flow | 1 | 2014 | 424 | 0.100 |
Why?
| | Monitoring, Physiologic | 1 | 2014 | 249 | 0.100 |
Why?
| | Collagen | 1 | 2014 | 415 | 0.100 |
Why?
| | Paternalism | 1 | 2011 | 4 | 0.100 |
Why?
| | Beneficence | 1 | 2011 | 18 | 0.100 |
Why?
| | Hematopoiesis | 1 | 2012 | 171 | 0.100 |
Why?
| | Disease Models, Animal | 3 | 2014 | 3531 | 0.090 |
Why?
| | Marketing of Health Services | 1 | 2011 | 12 | 0.090 |
Why?
| | Intraoperative Care | 1 | 2011 | 34 | 0.090 |
Why?
| | Personal Autonomy | 1 | 2011 | 39 | 0.090 |
Why?
| | Ethics, Medical | 1 | 2011 | 70 | 0.090 |
Why?
| | Aged | 6 | 2017 | 19061 | 0.090 |
Why?
| | Professional Practice | 1 | 2011 | 62 | 0.090 |
Why?
| | Treatment Failure | 1 | 2012 | 331 | 0.090 |
Why?
| | Suture Techniques | 1 | 2011 | 115 | 0.090 |
Why?
| | Informed Consent | 1 | 2011 | 161 | 0.090 |
Why?
| | Neovascularization, Physiologic | 1 | 2011 | 173 | 0.090 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2010 | 33 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1691 | 0.090 |
Why?
| | Male | 8 | 2016 | 55554 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1394 | 0.090 |
Why?
| | Nutrition Assessment | 1 | 2010 | 75 | 0.090 |
Why?
| | Radiography, Abdominal | 1 | 2010 | 32 | 0.090 |
Why?
| | Logistic Models | 2 | 2016 | 1840 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2762 | 0.080 |
Why?
| | Transplantation, Autologous | 1 | 2010 | 176 | 0.080 |
Why?
| | Organ Transplantation | 1 | 2011 | 159 | 0.080 |
Why?
| | North America | 1 | 2009 | 256 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2021 | 698 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 616 | 0.070 |
Why?
| | Wound Healing | 2 | 2023 | 258 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2009 | 275 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2011 | 668 | 0.070 |
Why?
| | Spinal Cord Injuries | 1 | 2010 | 174 | 0.070 |
Why?
| | Health Care Surveys | 1 | 2009 | 539 | 0.070 |
Why?
| | Quality of Life | 2 | 2022 | 2353 | 0.070 |
Why?
| | Back Injuries | 1 | 2006 | 5 | 0.070 |
Why?
| | Omentum | 1 | 2006 | 8 | 0.070 |
Why?
| | Cytokines | 1 | 2014 | 1840 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2012 | 858 | 0.070 |
Why?
| | Linear Models | 1 | 2008 | 768 | 0.070 |
Why?
| | Debridement | 1 | 2006 | 73 | 0.070 |
Why?
| | Case Management | 1 | 2006 | 62 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2008 | 1226 | 0.060 |
Why?
| | Mice | 4 | 2023 | 14860 | 0.060 |
Why?
| | Burns | 1 | 2009 | 237 | 0.060 |
Why?
| | Melanoma | 1 | 2012 | 619 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 1796 | 0.060 |
Why?
| | Antibodies, Monoclonal | 2 | 2023 | 1262 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2022 | 2710 | 0.060 |
Why?
| | Major Histocompatibility Complex | 1 | 2005 | 217 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3408 | 0.060 |
Why?
| | Sternum | 1 | 2023 | 17 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1016 | 0.060 |
Why?
| | Hydrocodone | 1 | 2023 | 15 | 0.050 |
Why?
| | Tissue Donors | 1 | 2005 | 316 | 0.050 |
Why?
| | Tobacco Use | 1 | 2023 | 60 | 0.050 |
Why?
| | Mandible | 1 | 2023 | 62 | 0.050 |
Why?
| | Physicians | 1 | 2011 | 772 | 0.050 |
Why?
| | Chemoprevention | 1 | 2023 | 88 | 0.050 |
Why?
| | Pregnancy | 1 | 2014 | 5517 | 0.050 |
Why?
| | Perfusion | 1 | 2022 | 148 | 0.050 |
Why?
| | Umbilicus | 1 | 2022 | 14 | 0.050 |
Why?
| | Transplantation Immunology | 1 | 2002 | 30 | 0.050 |
Why?
| | Peripheral Nerves | 1 | 2002 | 64 | 0.050 |
Why?
| | Cicatrix | 1 | 2022 | 50 | 0.050 |
Why?
| | Insurance, Health | 1 | 2023 | 244 | 0.050 |
Why?
| | Erlotinib Hydrochloride | 1 | 2021 | 64 | 0.050 |
Why?
| | Musculoskeletal System | 1 | 2001 | 43 | 0.040 |
Why?
| | Lymphocyte Depletion | 1 | 2001 | 116 | 0.040 |
Why?
| | Physical Therapy Modalities | 1 | 2023 | 264 | 0.040 |
Why?
| | Outpatients | 1 | 2023 | 326 | 0.040 |
Why?
| | Receptors, CCR4 | 1 | 2020 | 15 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 314 | 0.040 |
Why?
| | Inhibitory Concentration 50 | 1 | 2020 | 74 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 66 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 430 | 0.040 |
Why?
| | Dopamine | 1 | 2022 | 236 | 0.040 |
Why?
| | Forelimb | 1 | 1999 | 24 | 0.040 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 116 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2022 | 554 | 0.040 |
Why?
| | Lymphocytes | 1 | 2001 | 330 | 0.040 |
Why?
| | Veterans | 1 | 2010 | 1248 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 555 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 2019 | 32 | 0.040 |
Why?
| | Immunity, Cellular | 1 | 2001 | 248 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2019 | 105 | 0.040 |
Why?
| | Tacrolimus | 1 | 1999 | 134 | 0.040 |
Why?
| | Skin | 1 | 2003 | 655 | 0.040 |
Why?
| | Margins of Excision | 1 | 2017 | 29 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2023 | 681 | 0.040 |
Why?
| | Carcinoma, Lobular | 1 | 2017 | 44 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2019 | 298 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2020 | 1230 | 0.030 |
Why?
| | Narcotics | 1 | 2016 | 44 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 367 | 0.030 |
Why?
| | Cost Savings | 1 | 2016 | 74 | 0.030 |
Why?
| | Anesthetics, Local | 1 | 2016 | 81 | 0.030 |
Why?
| | Nerve Block | 1 | 2016 | 60 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2021 | 785 | 0.030 |
Why?
| | Biopsy | 1 | 2019 | 1036 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 537 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 287 | 0.030 |
Why?
| | Models, Statistical | 1 | 2018 | 599 | 0.030 |
Why?
| | Tissue Expansion Devices | 1 | 2014 | 4 | 0.030 |
Why?
| | Tissue Expansion | 1 | 2014 | 11 | 0.030 |
Why?
| | Cellulitis | 1 | 2014 | 45 | 0.030 |
Why?
| | Equipment Failure Analysis | 1 | 2014 | 132 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 544 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2017 | 490 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4405 | 0.030 |
Why?
| | Leukocyte Transfusion | 1 | 2012 | 2 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1518 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2013 | 6344 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 172 | 0.020 |
Why?
| | Transcription Factors | 1 | 2019 | 1528 | 0.020 |
Why?
| | Fluorescence | 1 | 2011 | 148 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2013 | 739 | 0.020 |
Why?
| | Equipment Design | 1 | 2011 | 508 | 0.020 |
Why?
| | Comorbidity | 1 | 2014 | 1448 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4099 | 0.020 |
Why?
| | Young Adult | 2 | 2013 | 10455 | 0.020 |
Why?
| | Smoking | 1 | 2014 | 1380 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 900 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2004 | 201 | 0.010 |
Why?
| | Obesity | 1 | 2014 | 2507 | 0.010 |
Why?
| | Antigens, Surface | 1 | 2001 | 146 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 3881 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2004 | 1736 | 0.010 |
Why?
| | Adolescent | 1 | 2012 | 17831 | 0.010 |
Why?
|
|
Mathes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|